Nordic Nanovector Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 39
Employees
  • Stock Symbol
  • NANOV
Stock Symbol
  • Share Price
  • $3.05
  • (As of Thursday Closing)

Nordic Nanovector General Information

Description

Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted therapeutics to improve the lives of patients with haematological cancers, such as non-Hodgkin lymphoma and leukaemia. The company's main clinical stage product is Betalutin.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
OSL
Primary Office
  • Kjelsåsveien 168 B
  • 0884 Oslo
  • Norway
+47 22 00 00 00

Nordic Nanovector Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nordic Nanovector Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.05 $3.18 $1.36 - $4.14 $299M 98M 683K -$0.63

Nordic Nanovector Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 233,125 105,967 200,761 228,048
Revenue 0 0 0 0
EBITDA (44,451) (42,526) (48,260) (41,664)
Net Income (46,171) (44,076) (49,254) (41,477)
Total Assets 60,447 36,853 58,475 54,358
Total Debt 208 535 2,077 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nordic Nanovector Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nordic Nanovector‘s full profile, request access.

Request a free trial

Nordic Nanovector Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nordic Nanovector ASA is a biopharmaceutical company. It is engaged in the development and commercialization of targeted
Biotechnology
Oslo, Norway
39 As of 2021
00000
000000000 00000

00000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ulla
0000000000000
Planegg, Germany
000 As of 0000
00000
0000 0000-00-00
000000000 00000

00000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000000
Boston, MA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nordic Nanovector Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediGene Formerly VC-backed Planegg, Germany 000 00000 000000000 00000
00000000 00000000 Formerly VC-backed Boston, MA 000 00000 00000000000 00000
000000 Formerly VC-backed Monrovia, CA 000 00000 00000000 00000
000000 00000000 Corporation Mont-Saint-Guibert, Belgium 00 00000 000000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
You’re viewing 5 of 30 competitors. Get the full list »

Nordic Nanovector Executive Team (16)

Name Title Board Seat Contact Info
Peter Braun Chief Executive Officer
Malene Brondberg Chief Financial Officer
Marco Renoldi Chief Operating Officer
Lars Nieba Ph.D Chief Technology Officer
Jostein Dahle Ph.D Chief Scientific Officer & Co-Founder
You’re viewing 5 of 16 executive team members. Get the full list »

Nordic Nanovector Board Members (13)

Name Representing Role Since
Björn Odlander Ph.D HealthCap Board Member 000 0000
Hilde Steineger Ph.D Self Board Member 000 0000
Johan Christenson Self Board Observer 000 0000
Mårten Steen Ph.D HealthCap Board Member 000 0000
Olav Steinnes Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Nordic Nanovector Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nordic Nanovector Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nordic Nanovector‘s full profile, request access.

Request a free trial